Journal of pain and symptom management
-
J Pain Symptom Manage · Dec 2022
Symptom Management Experience of End-of-Life Family Caregivers: a Population-Based Study.
In the United States, 30% of all deaths occur at home. Effective symptom management is integral to quality end-of-life (EOL) care. Family caregivers play a major role in EOL symptom management. Recent federal policies emphasize the need to improve training and support for family caregivers. ⋯ These findings underscore the need to improve training and support for family caregivers in EOL symptom management.
-
J Pain Symptom Manage · Dec 2022
ReviewThe Application of Minimal Clinically Important Differences in Palliative Research: Interpretation of Results of a Systematic Review.
Interpreting clinical meaningfulness of patient reported outcomes (PROs) in palliative care research is key in evidence-based practice. Minimal clinically important differences (MCIDs) can help interpret whether changes in PROs are meaningful to patients. ⋯ Incorporating MCIDs affected the interpretation of almost all PROs in the systematic review. MCIDs are important measures of clinical meaningfulness for the interpretation of palliative care research involving PROs. Researchers should consider using instruments with well-established MCIDs and incorporate MCIDs, when available, in study design and interpretation.
-
J Pain Symptom Manage · Dec 2022
Randomized Controlled TrialVideo and In-Person Palliative Care Delivery Challenges Before and During the COVID-19 Pandemic.
Palliative care (PC) clinicians faced many challenges delivering outpatient care during the coronavirus-19 (COVID-19) pandemic. ⋯ Technical difficulties related to PC video visits improved, whereas in-person visit challenges related to absent patients' family members worsened during the pandemic.
-
J Pain Symptom Manage · Dec 2022
Rapid titration with intravenous oxycodone for severe cancer pain and oral conversion ratio.
to assess a dose titration with intravenous oxycodone to achieve rapid pain relief of cancer pain of severe intensity. The second objective was to provide a conversion ratio with the oral route. ⋯ Rapid intravenous oxycodone dose titration resulted in rapid pain relief. The intravenous-oral conversion ratio of 1:2 is reliable. Further studies are necessary to confirm this preliminary observation.